Albany, NY -- (SBWIRE) -- 11/11/2016 -- Menotropin is a substance used for the treatment for infertility cases. Menotropin is also called as (human menopausal gonadotropin or HMG) consisting of equal proportion of follicle stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are extracted from urine of post menopausal women. Menotropin is extensively used for triggering the production of FSH and LH hormones in the body for stimulating ovaries to make eggs. Hence, it is used to overcome the pregnancy problem by releasing the mature egg.

View Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1667

In addition, menotropin is also used to produce multiple eggs for in vitro fertilization. Moreover, menotropin also stimulates the production of sperm in men where men possess functional testes but suffer from hormonal stimulation.

Factor such as rising cases of infertility is likely to increase the demand of menotropin globally. Infertility is caused due to wide range of factors such as DNA damage, general factors (diabetes, thyroid and adrenal disease), environmental factors (industrial toxins, tobacco smoking, and alcohol and drug consumption) and other hormonal related factors. It has been recognized as a high societal impact causing disease by American Society for Reproductive Medicine (ASRM), the American College of Obstertricinas and Gynecologists (ACOG) and WHO. It is estimated that approximately 7.3 million people are affected with infertility in the US.

However, usage of menotropin is associated with several side effects which act as a restraint for the growth of the market. Consumption of menotropin increases the likelihood of multiple births which poses a risk to mother and fetus. Additionally factors such as allergic reactions, ovarian enlargement, pain, fever, diarrhea and others are also side effects of menotropin.

Some of the market players in this industry are Merck Sorono S.A., Ferring Pharmaceuticals Inc, Bharat Serums and Vaccines Limited, Angelini Farmaceutica S.A., Emcure Pharmaceuticals Ltd and others.

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com